Nephrologist offers prevention advice related to the use of cisplatin, gemcitabine, and other agents.

Higher dose fails to lower the death rate among critically ill patients with acute kidney injury.

Greek researchers who studied 170 ICU patients with acute kidney injury (AKI) found that the most common contributing factor to AKI was sepsis, which was present in 45% of cases, an epidemiologic study found.

Acute kidney injury (AKI) is known to increase in-hospital mortality, but new findings suggest that it also increases long-term mortality risk independent of residual kidney function.

The Achilles heel of solid organ transplantation is progressive CKD. Although transplant-associated renal dysfunction is often multifactorial, calcineurin inhibitor (CNI) nephrotoxicity is thought to be a major contributor.

Fluid overload greater than 20% at the start of continuous renal replacement therapy (CRRT) increases the risk of death among pediatric ICU patients with acute kidney injury, researchers concluded.

HOLLYWOOD, Fla.— Using a novel drug-delivery system to infuse fenoldopam and other vasodilators directly into the kidneys may improve recovery from acute kidney injury (AKI), according to a small study showing that this approach dramatically reduced 28-day mortality when compared with historical outcomes.

Continuous and intermittent renal replacement therapies for patients with acute kidney injury (AKI) are associated with similar outcomes, data show.

Protection of renal function is a primary concern of physicians who manage surgical or medical diseases of the kidney, such as renal tumors, urinary calculi, renal vascular disease, or ureteropelvic junction obstruction.

Surgeons at Johns Hopkins University in Baltimore successfully removed a healthy donor kidney laparoscopically through a small incision in the back of the donor's vagina.